Annoroad Gene Technology benefits from intellectual property rights in biotechnology and healthcare industry. At the end of this September, Annoroad passed the authentication for its implementation of the national standard of Enterprise Intellectual Property Management (GB/T29490-2013), and obtained the Authentication Certificate of Intellectual Property Management System recognized by the Certification and Accreditation Administration of the People's Republic of China. "This illustrates how our standard management system for intellectual property rights has been implemented throughout the whole process from R&D and production to sales and procurement. We have reached a new level in the standardized management, systematic protection, and market-oriented application of intellectual property rights, and can now better facilitate the application of innovation achievements," said Wang Juan, Director of Intellectual Property Rights at Annoroad.

Relevant policies

Intellectual property policies for the "Two Zones"

Read more

Annoroad is dedicated to the commercial application of genomic technology in human medicine and health. What started as a small start-up with only one office has now grown into a leading entity in China's genomic industry. It was selected as one of the top 30 most technologically advanced companies in China, with annual sales revenue of CNY 600 million.